13Feb
Ahead of the pack: US M&A 2019: Biotech boosts US healthcare M&A in 2019
The healthcare sector (incorporating pharma, medical and biotech) has seen M&A valued at US$256.5 billion across 645 deals in 2019. This is a decrease of 9 percent by volume, but an increase of 121 percent by value....
By:
White & Case LLP
Related
I proudly presented my new ENHANCED driver’s license to the TSA agent at Newark International Airpo...
Read More >
News about severe financial difficulties at the Brattleboro Retreat quickly spread throughout the St...
Read More >
At both the state and federal level, antitrust enforcement agencies continue to pursue successful ch...
Read More >
The Empire State Development Corporation (“ESDC”) issued guidance over the weekend clarifying the ...
Read More >
On 26 July 2019, the Greek Supervisory Authority (SA) found Pricewaterhouse Coopers (“PwC”) not co...
Read More >
On June 12, 2019, the Seventh Circuit Court of Appeals held in Richardson v. Chicago Transit Authori...
Read More >